ELI LILLY & Co is 98.5x more valuable than MADRIGAL PHARMACEUTICALS, INC. by market capitalization ($1.070 T vs $10.87 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MDGL | LLY |
|---|---|---|
| Market cap | $10.87 B | $1.070 T |
| US-listed rank | #898 | #10 |
| Revenue (latest FY) | $958.40M | $65.18B |
| Net income (latest FY) | -$288.28M | $20.64B |
| Net margin | -30.1% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 1,184 | 989 |
ELI LILLY & Co is 98.5x more valuable than MADRIGAL PHARMACEUTICALS, INC. by market capitalization ($1.070 T vs $10.87 B).
In their latest fiscal years, MADRIGAL PHARMACEUTICALS, INC. reported $958.40M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: MADRIGAL PHARMACEUTICALS, INC. and ELI LILLY & Co, or browse the full rankings.